FDA approves blood-thinning drug Brilinta to treat acute coronary syndromes

Posted by Food and Drug Administration--Press Releases on Wednesday Jul 20, 2011 Under News

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

Be Sociable, Share!

Comments are closed.